h1

001007648 001__ 1007648
001007648 005__ 20250719052322.0
001007648 0247_ $$2HSB$$aeva578704
001007648 0247_ $$2ISSN$$a2152-2650
001007648 0247_ $$2ISSN$$a2152-2669
001007648 0247_ $$2SCOPUS$$aSCOPUS:2-s2.0-85184267458
001007648 0247_ $$2WOS$$aWOS:001221080700001
001007648 0247_ $$2doi$$a10.1016/j.clml.2024.01.005
001007648 0247_ $$2pmid$$apmid:38278737
001007648 0247_ $$2datacite_doi$$a10.18154/RWTH-CONV-254031
001007648 037__ $$aRWTH-CONV-254031
001007648 041__ $$aEnglish
001007648 1001_ $$aKantarjian, Hagop M.$$b0$$eCorresponding author
001007648 245__ $$aA Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia$$honline
001007648 260__ $$c2024
001007648 3367_ $$00$$2EndNote$$aJournal Article
001007648 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal
001007648 3367_ $$2BibTeX$$aARTICLE
001007648 3367_ $$2DRIVER$$aarticle
001007648 3367_ $$2DataCite$$aOutput Types/Journal article
001007648 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001007648 591__ $$aCanada
001007648 591__ $$aGermany
001007648 591__ $$aItaly
001007648 591__ $$aUSA
001007648 7001_ $$aJabbour, Elias J.$$b1
001007648 7001_ $$aLipton, Jeffrey H.$$b2
001007648 7001_ $$aCastagnetti, Fausto$$b3
001007648 7001_ $$0P:(DE-82)IDM06025$$aBrümmendorf, Tim Henrik$$b4$$urwth
001007648 773__ $$0PERI:(DE-600)2540998-0$$a10.1016/j.clml.2024.01.005$$n5$$p285-297$$tClinical lymphoma, myeloma & leukemia$$v24$$x2152-2650
001007648 8564_ $$uhttps://publications.rwth-aachen.de/record/1007648/files/1007648.pdf$$yOpenAccess
001007648 909CO $$ooai:publications.rwth-aachen.de:1007648$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001007648 9101_ $$0I:(DE-588b)36225-6$$6P:(DE-82)IDM06025$$aRWTH Aachen$$b4$$kRWTH
001007648 9141_ $$y2024
001007648 9151_ $$0StatID:(DE-HGF)0031$$2StatID$$aPeer reviewed article$$x0
001007648 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
001007648 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001007648 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCL LYMPH MYELOM LEUK : 2022$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001007648 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-26
001007648 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
001007648 9201_ $$0I:(DE-82)531040-2_20140620$$k531040-2$$lKlinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Onkologie und Hämatologie)$$x0
001007648 961__ $$z2025-03-20
001007648 970__ $$aeva578704
001007648 980__ $$aI:(DE-82)531040-2_20140620
001007648 980__ $$aUNRESTRICTED
001007648 980__ $$aVDB
001007648 980__ $$ajournal
001007648 9801_ $$aFullTexts